Lithium (Li)‐metal batteries (LMBs) with high‐voltage cathodes and limited Li‐metal anodes are crucial to realizing high‐energy storage. However, functional electrolytes that are compatible with both high‐voltage cathodes and Li anodes are required for their developments. In this study, the use of a moderate‐concentration LiPF6 and LiNO3 dual‐salt electrolyte composed of ester and ether co‐solvents (fluoroethylene carbonate/dimethoxyethane, FEC/DME), which forms a unique Li+ solvation with aggregated dual anions, that is, PF6− and NO3−, is proposed to stabilize high‐voltage LMBs. Mechanistic studies reveal that such a solvation sheath improves the Li plating/stripping kinetics and induces the generation of a solid electrolyte interphase (SEI) layer with gradient heterostructure and high Young's modulus on the anode, and a thin and robust cathode electrolyte interface (CEI) film. Therefore, this novel electrolyte enables colossal Li deposits with a high Coulombic efficiency (≈98.9%) for 450 cycles at 0.5 mA cm−2. The as‐assembled LiǁLiNi0.85Co0.10Al0.05O2 full batteries deliver an excellent lifespan and capacity retention at 4.3 V with a rigid negative‐to‐positive capacity ratio. This electrolyte system with a dual‐anion‐aggregated solvation structure provides insights into the interfacial chemistries through solvation regulation for high‐voltage LMBs.
Although aqueous Zn batteries have become a more sustainable alternative to lithium‐ion batteries owing to their intrinsic security, their practical applications are limited by dendrite formation and hydrogen reactions. The first application of a rare earth metal type addition to Zn batteries, cerium chloride (CeCl3), as an effective, low‐cost, and green electrolyte additive that facilitates the formation of a dynamic electrostatic shielding layer around the Zn protuberance to induce uniform Zn deposition is presented. After introducing CeCl3 additives, the electrochemical characterizations, in situ optical microscopy observation, in situ differential electrochemical mass spectrometry, along with density functional theory calculations, and finite element method simulations reveal resisted Zn dendritic growth and enhanced electrolyte stability. As a result, the Zn–Zn cells using the CeCl3 additive exhibit a long cycling stability of 2600 h at 2 mA cm−2, an impressive cumulative areal capacity of 3.6 Ah cm−2 at 40 mA cm−2, and a high Coulombic efficiency of ≈99.7%. The fact that the Zn–LiFePO4 cells with proposed electrolyte retain capacity significantly better than the additive‐free case is even more exciting.
Carbonate-based electrolytes have been extensively employed in commercial Li-ion batteries, but they faces numerous interphasial stability challenges while supporting the high-voltage cathode chemistries and lithium metal anode, which result in...
Modern network science has provided exciting new opportunities for understanding the human brain as a complex network of interacting regions. The improved knowledge of human brain network architecture has made it possible for clinicians to detect the network changes in neurological diseases. Generalized tonic-clonic seizure (GTCS) is a subtype of epilepsy characterized by generalized spike-wave discharge involving the bilateral hemispheres during seizure. Network researches in adults with GTCS exhibited that GTCS can be conceptualized as a network disorder. However, the overall organization of the brain structural covariance network in children with GTCS remains largely unclear.Here, we used a graph theory method to assess the gray matter structural covariance network organization of 14 pediatric patients diagnosed with GTCS and 29 healthy control children. The group differences in regional and global topological properties were investigated. Results revealed significant changes in nodal betweenness locating in brain regions known to be abnormal in GTCS (the right thalamus, bilateral temporal pole, and some regions of default mode network). The network hub analysis results were in accordance with the regional betweenness, which presented a disrupted regional topology of structural covariance network in children with GTCS. To our knowledge, the present study is the first work reporting the changes of structural topological properties in children with GTCS. The findings contribute new insights into the understanding of the neural mechanisms underlying GTCS and highlight critical regions for future neuroimaging research in children with GTCS.
An artificial lithium‐nitrate (LiNO3)‐rich layer (LN‐RL) is developed to address dendritic lithium (Li) growth by a fusing–infusing strategy, in which LiNO3 is loaded into stainless steel mesh and a Li‐metal anode (LN‐RL@Li) is obtained by casting this LN‐RL onto Li foil. The LN‐RL enables fast Li deposition kinetics in carbonates and endows LN‐RL@Li with excellent cycleability. The underneath mechanism on the contribution of LN‐RL is uncovered by detailed characterizations combining with theoretical simulations. The LN‐RL promotes the desolvation and capacitive adsorption of Li ions and induces in‐plane Li growth along the edges of preplated Li with planar morphology. The improved cycleability of LN‐RL(@Li) is demonstrated by LiǁCu cell that presents a coulombic efficiency of 97.2% after 280 cycles and LiǁLi cell that proceeds over 1000 h at 0.5 mA cm−2 in carbonates. Additionally, the LiǁLiFePO4 cell shows a capacity retention of 58% after 400 cycles at 1 C (1 C = 170 mA g−1), compared to the 35% after 180 cycles for the control. This work presents not only a promising strategy for practical applications of Li‐metal batteries, but also a new understanding on the role of nitrate in Li plating/stripping kinetics.
An experiment was conducted to determine the effects of different mycotoxin adsorbents including esterified glucomannan (EGM), hydrated sodium calcium aluminosilicate (HSCAS) and compound mycotoxin adsorbent (CMA) on performance, blood parameters, and liver pathological changes in broilers fed mold-contaminated feed. Two hundred and forty 10-day-old broilers were randomly assigned to one of the five dietary treatments including: i) control diet; ii) mold-contaminated diet; iii) moldcontaminated diet+0.05% EGM; iv) mold-contaminated diet+0.2% HSCAS; v) mold-contaminated diet+0.1% CMA. At 35-days-old, blood and liver tissue samples were collected for analysis. 0.1% CMA improved ADG and ADFI during 10-42 d compared to the moldcontaminated group (p<0.05). The mold-contaminated diet increased total white blood cell (WBC) number, haemoglobin (Hgb) concentration, hematocrit (Hct) level, serum aspartate aminotransferase (AST) and γ-glutamyl transferase (GGT) activities, and decreased red blood cell (RBC) number and serum globulin (GLB) and urea nitrogen (BUN) concentrations (p<0.05). The three mycotoxin adsorbents alleviated the alteration of RBC, WBC, Hgb and AST caused by the mold-contaminated diet. Furthermore, 0.1% CMA increased GLB concentration and decreased Hct level and GGT activity (p<0.05). Liver superoxide dismutase (SOD) activity was reduced, and myeloperoxidase (MPO) activity was increased by the mold-contaminated diet (p<0.05). Both EGM and HSCAS prevented the increase of MPO activity (p<0.05). Liver lesion, including severe vacuolar degeneration of hepatocytes, was observed in chicks fed the mold-contaminated diet. 0.05% EGM prevented these effects except for biliary hyperplasia and mild vacuolar degeneration. 0.2% HSCAS showed medium vacuolar degeneration of hepatocytes. Liver of broilers fed 0.1% CMA revealed a mild vacuolar degeneration. These results indicate that a mold-contaminated diet results in adverse effects on blood parameters and liver morphology. 0.05% EGM and 0.2% HSCAS partially alleviated the adverse effects. However, 0.1% CMA almost completely ameliorated the adverse effects.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.